scientific name for retatrutide Retatrutide—A Game Changer in Obesity Pharmacotherapy Retatrutide - Wikipedia

Some degree of weight gain after stopping GLP-1 medication can be normal

Trademark Acknowledgment : GLPro is a registered trademark

The SURMOUNT-5 trial, published in The New England Journal of Medicine , directly compared tirzepatide to semaglutide and found tirzepatide produced 47% greater relative weight loss at 72 weeks, 20.2% of body weight versus 13.7%

Liver energy metabolism reprogramming: GLP-1RA reduces hepatic glucose output by decreasing hepatic FFA uptake and the expression of key gluconeogenesis enzymes such as PEPCK and G6Pase, while promoting liver sensitivity to insulin, transforming the liver from an "energy output organ" to an "energy storage organ"

MHRA calls on public to report side effects and suspected fakes during MedSafetyWeek

Blood pressure and heart rate monitoring Cardiovascular monitoring remains paramount for GLP-1 non-responders transitioning to sympathomimetic agents like phentermine